2022 - Research.com Best Scientist Award
2014 - BBVA Foundation Frontiers of Knowledge Award
2006 - Robert J. and Claire Pasarow Foundation Medical Research Award
2004 - Member of the National Academy of Medicine (NAM)
2004 - Louisa Gross Horwitz Prize, Columbia University
2001 - Keio Medical Science Prize, Keio University, Tokyo, Japan
2000 - J. Allyn Taylor International Prize in Medicine, Robarts Research Institute
1998 - Member of the National Academy of Sciences
1994 - Canada Gairdner International Award
1994 - Charles S. Mott Prize, General Motors Cancer Research Foundation
1992 - Fellow of the American Academy of Arts and Sciences
1987 - Fellow of the Royal Society, United Kingdom
His primary areas of study are Cell biology, Phosphorylation, Molecular biology, Biochemistry and Cyclin-dependent kinase 2. His work is dedicated to discovering how Cell biology, Cell cycle are connected with Mitosis and Nuclear protein and other disciplines. His Phosphorylation research is multidisciplinary, relying on both Tyrosine, Transcription factor and Kinase.
The Molecular biology study combines topics in areas such as Epidermal growth factor, Ubiquitin, Gene product, Gene expression and Cyclin E. The study incorporates disciplines such as Protein-Serine-Threonine Kinases and Akt/PKB signaling pathway in addition to Cyclin-dependent kinase 2. Tony Hunter combines subjects such as Wee1 and Protein tyrosine phosphatase with his study of Protein phosphorylation.
His main research concerns Cell biology, Molecular biology, Biochemistry, Phosphorylation and Kinase. As a part of the same scientific study, Tony Hunter usually deals with the Cell biology, concentrating on Cell cycle and frequently concerns with Mitosis. His Molecular biology study deals with RNA intersecting with Messenger RNA.
Tony Hunter interconnects Tyrosine and Histidine in the investigation of issues within Phosphorylation. His Protein tyrosine phosphatase research is multidisciplinary, incorporating elements of Phosphatase and Receptor tyrosine kinase. His MAP2K7 study incorporates themes from c-Raf and MAP kinase kinase kinase.
Tony Hunter mostly deals with Cell biology, Phosphorylation, Biochemistry, Cancer research and Kinase. The various areas that he examines in his Cell biology study include SUMO protein, Ubiquitin, Genetics and Transcription. His biological study focuses on Protein phosphorylation.
His biological study deals with issues like Tyrosine phosphorylation, which deal with fields such as Protein tyrosine phosphatase. His Kinase research incorporates themes from Histidine kinase, Cell cycle and Isozyme. His work focuses on many connections between Protein kinase C and other disciplines, such as Mutation, that overlap with his field of interest in Molecular biology.
The scientist’s investigation covers issues in Phosphorylation, Biochemistry, Cell biology, Kinase and Protein phosphorylation. His Phosphorylation research includes elements of Signal transduction, Nucleoside-diphosphate kinase and Histidine. His work deals with themes such as Cell cycle checkpoint, Transcription factor, Ubiquitin ligase and DNA damage, which intersect with Cell biology.
His work carried out in the field of Kinase brings together such families of science as Autophagy, Cancer, Cell cycle, Cancer research and Phosphoglycerate kinase 1. As part of one scientific family, Tony Hunter deals mainly with the area of Cancer, narrowing it down to issues related to the Gene, and often Molecular biology. His Protein phosphorylation study combines topics in areas such as Tyrosine, Protein tyrosine phosphatase, Posttranslational modification, Proteins metabolism and Expanded genetic code.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Protein Kinase Complement of the Human Genome
G. Manning;D. B. Whyte;R. Martinez;T. Hunter.
Science (2002)
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.
Steven K. Hanks;Anne Marie Quinn;Tony Hunter.
Science (1988)
Oncogenic kinase signalling.
Peter Blume-Jensen;Tony Hunter.
Nature (2001)
Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling
Tony Hunter.
Cell (1995)
Signaling--2000 and beyond.
Tony Hunter.
Cell (2000)
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
Tony Hunter;Jonathan Pines.
Cell (1994)
Transforming gene product of Rous sarcoma virus phosphorylates tyrosine
Tony Hunter;Bartholomew M. Sefton.
Proceedings of the National Academy of Sciences of the United States of America (1980)
Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification.
Steven K. Hanks;Tony Hunter.
The FASEB Journal (1995)
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Hideo Toyoshima;Tony Hunter.
Cell (1994)
Protein-tyrosine kinases.
Tony Hunter;Jonathan A. Cooper.
Annual Review of Biochemistry (1985)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Fred Hutchinson Cancer Research Center
Salk Institute for Biological Studies
Zhejiang University
Institute of Cancer Research
Salk Institute for Biological Studies
Scripps Research Institute
Vanderbilt University
Beth Israel Deaconess Medical Center
Salk Institute for Biological Studies
Hong Kong University of Science and Technology
Simon Fraser University
University of York
Wellcome/Cancer Research UK Gurdon Institute
Changhua Christian Hospital
University of Exeter
University of Georgia
University of North Carolina at Chapel Hill
Lancaster University
Kantonsspital St. Gallen
City University of New York
University of Bologna
Harvard University
Universidade Federal de Santa Catarina
Innsbruck Medical University
University of Michigan–Ann Arbor
Queen's University Belfast